OTC · BICX
Healthcare · Medical - Care Facilities
$0.25
Up+$0.03 (+12.11%)
Updated Aug 26, 2026, 10:48 AM
SID Score
2.8/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 12 trading sessions · Daily adjusted prices
BICX closed at $0.22 after 12 trading sessions, down 25.67% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | $0.2641 | $0.2641 | $0.223 | $0.223 | 16.5K |
| Aug 19, 2026 | $0.2339 | $0.25 | $0.2277 | $0.24 | 20.01K |
| Aug 18, 2026 | $0.24 | $0.24 | $0.24 | $0.24 | 1.78K |
| Aug 17, 2026 | $0.20 | $0.24 | $0.20 | $0.24 | 2.4K |
| Aug 14, 2026 | $0.2501 | $0.2661 | $0.152 | $0.152 | 23.8K |
| Aug 11, 2026 | $0.251 | $0.28 | $0.251 | $0.28 | 11.68K |
| Aug 10, 2026 | $0.30 | $0.30 | $0.30 | $0.30 | 600 |
| Aug 7, 2026 | $0.298 | $0.298 | $0.298 | $0.298 | 761 |
| Aug 4, 2026 | $0.2501 | $0.298 | $0.2501 | $0.298 | 1.68K |
| Aug 3, 2026 | $0.2751 | $0.2751 | $0.2751 | $0.2751 | 1.1K |
| Jul 31, 2026 | $0.2661 | $0.2661 | $0.26 | $0.26 | 2.72K |
| Jul 28, 2026 | $0.30 | $0.30 | $0.30 | $0.30 | 3.57K |
The latest Smart Investors Daily articles mentioning BICX.
BICX research
Company profile and research snapshot.
BIOCORRX INC NEW
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
defenseworld.net · Nov 30, 2025
Biocorrx (OTCMKTS:BICX - Get Free Report) and CVS Health (NYSE: CVS - Get Free Report) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, risk, valuation and profitability. Profitability This table compares Biocorrx and CVS Health's net
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning BICX.
No results
No recent SID articles mention BICX.
